![Nicklas Westerholm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicklas Westerholm
Vorstandsvorsitzender bei
EGETIS THERAPEUTICS AB
Vermögen: 330 238 $ am 31.05.2026
Profil
Nicklas Westerholm is currently Chief Executive Officer at Egetis Therapeutics AB since 2017, Chairman & Chief Executive Officer at Rare Thyroid Therapeutics International AB, and Independent Director at Spago Nanomedical AB since 2019.
Former positions include Head-Investor Relations at AstraZeneca PLC from 2011 to 2013 and VP-Project & Portfolio Management at AstraZeneca AB from 1995 to 2017.
Education includes undergraduate studies at the University of Stockholm and the Royal Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.05.2026 | 501’508 ( 0.11% ) | 330 238 $ | 31.05.2026 |
Aktive Positionen von Nicklas Westerholm
| Unternehmen | Position | Beginn |
|---|---|---|
| EGETIS THERAPEUTICS AB | Vorstandsvorsitzender | 16.06.2017 |
| SPAGO NANOMEDICAL AB | Direktor/Vorstandsmitglied | 08.05.2019 |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Nicklas Westerholm
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 01.06.2017 |
| ASTRAZENECA PLC | Investor Relations Kontakt | 08.09.2011 |
Ausbildung von Nicklas Westerholm
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Spago Nanomedical AB
 Spago Nanomedical AB BiotechnologyHealth Technology Acts as a biotechnology company | Health Technology |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Health Technology |
